OnKure Therapeutics, Inc. (OKUR)

CIK 1637715 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for OnKure Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097335
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002177
Aug 14, 2026SCHEDULE 13G/A0001493152-26-038382
Aug 13, 20268-K0001193125-26-347315
Aug 13, 20264/A0001622769-26-000006
Aug 11, 202640001622769-26-000002
Aug 11, 202640001889716-26-000002
Aug 11, 202640001748961-26-000002
Aug 11, 202640001193125-26-344874
Aug 11, 202640001692747-26-000004
Aug 11, 202640001921956-26-000003
Aug 11, 202640001547100-26-000005
Aug 11, 202640002037442-26-000002
Aug 11, 202640001609284-26-000004
Aug 11, 202640001240122-26-000006
Aug 11, 202640001644467-26-000002
Aug 10, 2026SCHEDULE 13G/A0001617201-26-000003
Aug 4, 2026424B50001193125-26-332839
Aug 4, 202610-Q0001193125-26-332773
Aug 4, 20268-K0001193125-26-332809
Jun 24, 202640001692747-26-000003
Jun 24, 202640001609284-26-000003
Jun 8, 202640001547100-26-000004
Jun 8, 202640001644467-26-000001
Jun 8, 202640001889716-26-000001